Management of severe pulmonary Langerhans cell histiocytosis in children (original) (raw)

Pediatric Pulmonology, 2020

Abstract

Patients with pulmonary Langerhans cell histiocytosis (LCH) typically have a benign course but may have extensive cystic lung disease with rare life‐threatening complications including multiple and recurrent pneumothoraces and respiratory failure. We report seven severely affected pediatric patients treated with chemotherapy, aggressive chest tube management, and pleurodesis of whom five survived. Patients with extraordinary amounts of pulmonary cystic disease and multiple pneumothoraces due to LCH can have remarkable, curative outcomes with early recognition, optimal LCH‐directed therapy, and supportive care.

Stephen Lowis hasn't uploaded this paper.

Let Stephen know you want this paper to be uploaded.

Ask for this paper to be uploaded.